Detalles de la búsqueda
1.
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.
Virol J
; 21(1): 70, 2024 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515117
2.
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine.
J Infect Dis
; 227(2): 251-255, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108092
3.
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine.
Clin Infect Dis
; 76(3): e299-e307, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675370
4.
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.
J Clin Microbiol
; 59(2)2021 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33139421
5.
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.
Front Immunol
; 14: 1106837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949953
6.
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.
World J Pediatr
; 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085470
7.
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
Lancet Microbe
; 4(9): e670-e682, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549680
8.
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination.
Nat Med
; 28(3): 486-489, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051989
9.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Nat Commun
; 13(1): 3700, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764637
10.
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.
Signal Transduct Target Ther
; 7(1): 397, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517469
11.
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Nat Commun
; 13(1): 4798, 2022 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970832
Resultados
1 -
11
de 11
1
Próxima >
>>